StockData
Evolent Health, Inc. logo

Evolent Health, Inc. (EVH) stock

EVHNYSEServices-Management ServicesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 7/3054% below fair value
$4.83−0.07 (-1.43%)

Close on Nov 16, 2026Market cap $546.08MP/E –Yield –

Evolent Health price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Evolent Health's price to sales ratio was 0.3× on Nov 11, 2026, against 0.2× a year earlier. Over the last 5 years it ranged from 0.1× to 3.1×, with a median of 1.5×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20260.3×+0.0
2025Dec 31, 20250.2×−0.3
2024Dec 31, 20240.5×−1.5
2023Dec 29, 20232.0×−0.1
2022Dec 30, 20222.1×−0.5
2021Dec 31, 20212.7×+1.2
2020Dec 31, 20201.5×+0.6
2019Dec 31, 20190.9×−1.9
2018Dec 31, 20182.8×+1.0
2017Dec 29, 20171.8×−1.5
2016Dec 30, 20163.3×−1.7
2015Dec 31, 20155.0×–

More Evolent Health figures

See a number that looks wrong?